Digital health is a term that refers to the use of digital technologies to improve health and healthcare. This includes a wide range of applications, such as electronic health records, telemedicine, health monitoring devices, and health-related apps and software. Digital health technologies can be used to improve the efficiency, effectiveness, and accessibility of healthcare, and to enable individuals to manage their own health and wellbeing more effectively. Digital health is an increasingly important area of healthcare, as it offers the potential to improve health outcomes and reduce costs. What is a digital health MVP?

Digital health products played a prominent role in addressing the COVID-19 pandemic and in helping caregivers and patients navigate their care in the past year. Going into 2022, remote monitoring, wearables, sensors, and other mobile health (mHealth) products are taking center stage in defining the future of medicine. "One of the clearest areas of excitement now and into the future is the sector of healthcare products referred to as wearables. These are devices like fitness trackers, heart monitors, and other devices that record in real time and communicate biometric data either directly to the user or to a connected platform for a variety of purposes, including coaching, intervention, analysis and even within clinical trials administration," notes a recent report from contract manufacturer Jabil, St. Petersburg, FL. The report, "Digital Health Technology Trends," finds that "the top three solution categories providers are developing or plan to develop are in patient monitoring, diagnostic equipment, and on-body or wearable devices (see Figure 1). As digital and mHealth capabilities have become an integral part of many medical devices and diagnostics, they have enabled a more agile and flexible healthcare system to emerge in the face of COVID-19. These products will continue to improve access to patient care. Digital transformation of healthcare is not just about adopting new digital technology, notes a recent position paper from medtech giant Philips. It's about reimagining healthcare for the digital age -- using the power of data, artificial intelligence (AI), cloud-based platforms, and new business models to improve health outcomes, lower the cost of care, and improve the human care experience for patients and staff alike."

It was the last question of the night and it hushed the entire room. An entrepreneur expressed his aggravation about the FDA's antiquated regulatory environment for AI-enabled devices to Dr. Joel Stein of Columbia University. Stein a leader in rehabilitative robotic medicine, sympathized with the startup knowing full well that tomorrow's exoskeletons will rely heavily on machine intelligence. Nodding her head in agreement, Kate Merton of JLabs shared the sentiment. Her employer, Johnson & Johnson, is partnered with Google to revolutionize the operating room through embedded deep learning systems. To better understand the frustration expressed at RobotLab, a review of the policies of the Food & Drug Administration (FDA) relative to medical devices and software is required.